z-logo
open-access-imgOpen Access
Choice of Systemic Drugs for the Management of Moderate-to-severe Psoriasis: A Cross-country Comparison Based on National Health Insurance Data
Author(s) -
É. Sbidian,
M. Mezzarobba,
Jason Shourick,
Cécile Billionnet,
Joël Coste,
Alain Weill,
Jérémie Rudant,
O. Chosidow,
Loes M. Hollestein,
Tamar Nijsten
Publication year - 2021
Publication title -
acta dermato venereologica
Language(s) - English
Resource type - Journals
eISSN - 1651-2057
pISSN - 0001-5555
DOI - 10.2340/00015555-3765
Subject(s) - psoriasis , acitretin , medicine , methotrexate , ustekinumab , systemic therapy , biological drugs , healthcare system , family medicine , health care , pediatrics , dermatology , disease , adalimumab , cancer , breast cancer , economic growth , economics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom